Nephron Sterile Compounding Center LLC recalls Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 16 mg/250 mL (64 mcg/mL*), 250 mL Single-Dose Container…
Lack of Assurance of Sterility
Read the official notice →- Date
- 2023-03-08
- Country
- United States
- Brand
- Nephron Sterile Compounding Center
- Product
- Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 16 mg/250 mL (64 mcg/mL*), 250 mL Single-Dose Container bottle, packaged…
- Classification
- Class II
- Units
- Nationwide in the USA
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Nephron Sterile Compounding Center recalls
- 2025-03-19
USNephron Sterile Compounding Center LLC recalls Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility, West…
Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.
- 2023-01-18
- US
- 2022-11-23
- US
Nephron Sterile Compounding Center LLC recalls PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500…
CGMP Deviations: Potential for cross contamination due to product carry over.
- 2022-08-24
- US
Nephron Sterile Compounding Center LLC recalls PF-Neostigmine Methylsulfate Injection, USP, 3 mg/3 mL (1 mg/mL), One 3 mL Unit-Dose Vial, packaged in 30 x 3 mL Sterile…
CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.
- 2022-07-27
- US
- 2022-06-08
- US
Other drugs & medical recalls in the United States
- 2023-03-08
- US
Accord Healthcare, Inc. recalls Dofetilide Capsules 250 mcg (0.25 mg) 60-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured…
CGMP Deviations: recalling drug products following an FDA inspection.
- US
Nephron Sc Inc recalls Sterile Water for Injection, USP, 30x5 mL Single-Dose Vials, Rx Only, Nephron 4500 12th Street Extension West Columbia, SC 29172, NDC…
CGMP Deviations: Potential product carryover.
- US
- US
Sciegen Pharmaceuticals Inc recalls Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788,…
Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.
- US
Alvogen, Inc recalls Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 51601, Distributed…
Sub-Potent Drug: Out of specification for assay at the 24 month interval.
- US
DuPont Nutrition USA, Inc recalls BD-102 NF, Microcrystalline Cellulose, NF, Ph. Eur., Jp., Net Content/Gross Weight 20.0 KG / 21.1 KG bulk container, Manufactured by:…
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
FDA · DrugDuPont Nutrition USA, IncProduct was distributed nationwide in the United States and Puerto Rico, and…Official notice →